Pliant Therapeutics Q3 net income USD -24.377 million

PLRX•2026-11-12

Pliant Therapeutics reported Q3 net income of USD -24.377 million, operating income of USD -25.742 million and operating expenses of USD 25.742 million.

1. Q3 results

Pliant Therapeutics reported Q3 net income of USD -24.377 million. Operating income and operating expenses were both reported as USD -25.742 million.

Pliant Therapeutics Q3 net income USD -24.377 million

1. Q3 results

Related News

US Foods appoints Lisa M. Lambert to board of directors

Knightscope Q3 revenue jumps 177% to $8.7 million

Shattuck Labs grants options for 384,000 shares to two new employees

Spero Therapeutics Q3 net loss widens on SP001 licensing payment

Xos Q3 revenue USD 5.5 million